169 related articles for article (PubMed ID: 37003283)
1. Pirfenidone in rheumatoid arthritis-associated interstitial lung disease.
Graudal N; Nielsen CT; Lindhardsen J
Lancet Respir Med; 2023 Jun; 11(6):e51. PubMed ID: 37003283
[No Abstract] [Full Text] [Related]
2. Pirfenidone in rheumatoid arthritis-associated interstitial lung disease - Authors' reply.
Hurwitz S; Maurer R; Solomon JJ; Rosas IO
Lancet Respir Med; 2023 Jun; 11(6):e52. PubMed ID: 37003284
[No Abstract] [Full Text] [Related]
3. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ; Danoff SK; Woodhead FA; Hurwitz S; Maurer R; Glaspole I; Dellaripa PF; Gooptu B; Vassallo R; Cox PG; Flaherty KR; Adamali HI; Gibbons MA; Troy L; Forrest IA; Lasky JA; Spencer LG; Golden J; Scholand MB; Chaudhuri N; Perrella MA; Lynch DA; Chambers DC; Kolb M; Spino C; Raghu G; Goldberg HJ; Rosas IO;
Lancet Respir Med; 2023 Jan; 11(1):87-96. PubMed ID: 36075242
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate in interstitial lung disease associated with rheumatoid arthritis.
Arboleya-Rodríguez L; Arias-Guillén M;
Reumatol Clin (Engl Ed); 2022; 18(7):441-442. PubMed ID: 35863987
[No Abstract] [Full Text] [Related]
6. Rheumatoid arthritis associated interstitial lung disease: a review.
Assayag D; Lee JS; King TE
Medicina (B Aires); 2014; 74(2):158-65. PubMed ID: 24736263
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of pirfenidone on fibroblast to myofibroblast transition in rheumatoid arthritis-associated interstitial lung disease via the downregulation of activating transcription factor 3 (ATF3).
Wu C; Lin H; Zhang X
Int Immunopharmacol; 2019 Sep; 74():105700. PubMed ID: 31228816
[TBL] [Abstract][Full Text] [Related]
8. A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.
Kawashiri SY; Kawakami A; Sakamoto N; Ishimatsu Y; Eguchi K
Rheumatol Int; 2012 Dec; 32(12):4023-6. PubMed ID: 20480164
[TBL] [Abstract][Full Text] [Related]
9. [Interstitial lung disease in rheumatoid arthritis].
Froidevaux-Janin S; Dudler J; Nicod LP; Lazor R
Rev Med Suisse; 2011 Nov; 7(318):2272-7. PubMed ID: 22400361
[TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy in interstitial lung disease associated with rheumatoid arthritis.
Fui A; Bergantini L; Selvi E; Mazzei MA; Bennett D; Pieroni MG; Rottoli P; Bargagli E
Intern Med J; 2020 Mar; 50(3):330-336. PubMed ID: 30963656
[TBL] [Abstract][Full Text] [Related]
11. Quantitative chest imaging and prediction of mortality in rheumatoid arthritis-associated interstitial lung disease.
McDermott G; Sparks JA
Rheumatology (Oxford); 2022 Nov; 61(12):4583-4584. PubMed ID: 35652728
[No Abstract] [Full Text] [Related]
12. Risk factors of patients with interstitial lung disease complicated with rheumatoid arthritis.
Zhao F; Zhang WD; Jiang YL; Liu W; Cao J
J Biol Regul Homeost Agents; 2020; 34(1):221-226. PubMed ID: 32253899
[No Abstract] [Full Text] [Related]
13. Answer to the Letter to the Editor: Methotrexate in interstitial lung disease associated with rheumatoid arthritis.
Carrasco Cubero C; Chamizo Carmona E
Reumatol Clin (Engl Ed); 2022; 18(7):440-441. PubMed ID: 34326036
[No Abstract] [Full Text] [Related]
14. Antifibrotic therapies in rheumatoid arthritis associated interstitial lung disease.
Bes C; Köybaşı G; İçaçan OC; Yalçın Mutlu M; Yıldırım F
Eur J Rheumatol; 2022 Jul; 9(3):176-179. PubMed ID: 35156636
[TBL] [Abstract][Full Text] [Related]
15. [Rheumatoid arthritis and lung - more than a minor aspect of the disease].
Fiehn C
Dtsch Med Wochenschr; 2015 Jun; 140(12):904-7. PubMed ID: 26069917
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid arthritis interstitial lung disease: mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug.
Saketkoo LA; Espinoza LR
Arch Intern Med; 2008 Aug; 168(15):1718-9. PubMed ID: 18695091
[No Abstract] [Full Text] [Related]
17. [Rheumatoid arthritis associated interstitial lung disease].
Rojas-Serrano J; Mejía M; Gaxiola M
Rev Invest Clin; 2012; 64(6 Pt 1):558-66. PubMed ID: 23513613
[No Abstract] [Full Text] [Related]
18. Refractory Rheumatoid Arthritis and Associated Interstitial Lung Disease: Could Abatacept be the Answer?
Ye W; Fifield MC; Östör AJ
J Clin Rheumatol; 2017 Mar; 23(2):125-126. PubMed ID: 28225518
[No Abstract] [Full Text] [Related]
19. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis.
Rojas-Serrano J; Herrera-Bringas D; Pérez-Román DI; Pérez-Dorame R; Mateos-Toledo H; Mejía M
Clin Rheumatol; 2017 Jul; 36(7):1493-1500. PubMed ID: 28585060
[TBL] [Abstract][Full Text] [Related]
20. Progressive fibrosing interstitial lung disease associated with systemic autoimmune diseases.
Fischer A; Distler J
Clin Rheumatol; 2019 Oct; 38(10):2673-2681. PubMed ID: 31423560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
